Skip to main navigation Skip to search Skip to main content

Comparison of active treatments for impaired glucose regulation: A Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): Study protocol for a randomized controlled trial

  • Peter A. Coventry*
  • , Peter Bower
  • , Amy Blakemore
  • , Liz Baker
  • , Mark Hann
  • , Angela Paisley
  • , Charlotte Renwick
  • , Jinshuo Li
  • , Atushi Ugajin
  • , Martin Gibson
  • *Corresponding author for this work
  • University of York
  • St Mary's Hospital, Manchester University Hospital NHS Foundation Trust
  • The Christie Hospital NHS Foundation Trust
  • Hitachi Europe Limited
  • The National Institute for Health Research (NIHR) School for Primary Care Research
  • Manchester Academic Health Science Centre (MAHSC)

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Diabetes is highly prevalent and contributes to significant morbidity and mortality worldwide. Behaviour change interventions that target health and lifestyle factors associated with the onset of diabetes can delay progression to diabetes, but many approaches rely on intensive one-to-one contact by specialists. Health coaching is an approach based on motivational interviewing that can potentially deliver behaviour change interventions by non-specialists at a larger scale. This trial protocol describes a randomized controlled trial (CATFISH) that tests whether a web-enhanced telephone health coaching intervention (IGR3) is more acceptable and efficient than a telephone-only health coaching intervention (IGR2) for people with prediabetes (impaired glucose regulation). Methods: CATFISH is a two-parallel group, single-centre individually randomized controlled trial. Eligible participants are patients aged ≥18 years with impaired glucose regulation (HbA1c concentration between 42 and 47 mmol/mol), have access to a telephone and home internet and have been referred to an existing telephone health coaching service at Salford Royal NHS Foundation Trust, Salford, UK. Participants who give written informed consent will be randomized remotely (via a clinical trials unit) to either the existing pathway (IGR2) or the new web-enhanced pathway (IGR3) for 9 months. The primary outcome measure is patient acceptability at 9 months, determined using the Client Satisfaction Questionnaire. Secondary outcome measures at 9 months are: cost of delivery of IGR2 and IGR3, mental health, quality of life, patient activation, self-management, weight (kg), HbA1c concentration, and body mass index. All outcome measures will be analyzed on an intention-to-treat basis. A qualitative process evaluation will explore the experiences of participants and providers with a focus on understanding usability of interventions, mechanisms of behaviour change, and impact of context on delivery and user acceptability. Qualitative data will be analyzed using Framework. Discussion: The CATFISH trial will provide a pragmatic assessment of whether a web-based information technology platform can enhance acceptability of a telephone health coaching intervention for people with prediabetes. The data will prove critical in understanding the role of web applications to improve engagement with evidence-based approaches to preventing diabetes. Trial registration:ISRCTN16534814. Registered on 7 February 2016.

Original languageEnglish
Article number424
JournalTrials
Volume17
Issue number1
DOIs
Publication statusPublished - 26 Aug 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Comparison of active treatments for impaired glucose regulation: A Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Cite this